A.O.R.N. dei Colli - Monaldi Hospital - Italy
Author Profile
Scopus
🎓 Early Academic Pursuits
Dr. Flavia Chiosi embarked on her academic journey with a Bachelor’s degree in Medicine and Surgery from the Second University of Naples, graduating in 2004 with top honors (110/110 e lode). Her early education laid a strong foundation for her subsequent specialization in ophthalmology. Driven by her passion for eye health and research, she completed a residency in Ophthalmology at the same institution from 2005 to 2010, where she graduated with distinction.
💼 Professional Endeavors
Dr. Chiosi's career spans a wide range of roles in clinical practice, research, and teaching. From 2010 to 2018, she honed her skills as an eye specialist at various prestigious institutions, including ASL Campane and Ospedale dei Pellegrini in Naples. She also served as an eye consultant for the Veteran Evaluation Service in Texas, USA, from 2017 to 2022. Currently, she is the Head Physician at the U.O.C. Oculistica at A.O.R.N. Monaldi and serves as an eye consultant at the department of Genetic and Rare Cardiovascular Diseases at A.O.R.N. dei Colli, Luigi Vanvitelli University.
🔬 Contributions and Research Focus
Dr. Chiosi's contributions to ophthalmology are both clinical and scientific. Her research activities have focused on retinal diseases, macular degeneration, and innovative imaging techniques. She has been a principal investigator in groundbreaking studies like the CR44829 (POYANG) and VOYAGER studies, which evaluate the efficacy of faricimab in treating retinal diseases. Additionally, her work has advanced the use of OCT, fluorescein angiography, and laser therapy in medical retina services. Her expertise has significantly enriched the field of ophthalmology, making her a sought-after leader in retinal imaging and therapy.
🌍 Impact and Influence
Dr. Chiosi has influenced the field of ophthalmology through her clinical and surgical expertise, particularly in anterior and posterior segment surgeries. Her leadership roles, including her responsibilities at A.O.R.N. Monaldi, highlight her ability to integrate clinical innovation with patient care. Her collaboration with renowned institutions like Bayer Health Care and her work in rare genetic cardiovascular diseases underscore her interdisciplinary influence.
🏆Academic Cites
Dr. Chiosi’s research and publications have earned recognition in academic and medical communities. Her involvement in clinical trials and her role as a scientific advisor reflect the widespread acknowledgment of her contributions. Her work is frequently cited by peers, demonstrating its relevance and impact on advancing ophthalmology practices and therapies.
🌟 Legacy and Future Contributions
Dr. Flavia Chiosi’s legacy is defined by her dedication to improving diagnostic and therapeutic approaches in ophthalmology. She has consistently pushed the boundaries of retinal disease research and surgery, ensuring better outcomes for patients. Her future contributions are expected to include pioneering advancements in clinical practices for maculopathies and diabetic eye diseases, as well as continued mentorship for aspiring ophthalmologists.
📝Ophthalmology
Dr. Chiosi's pioneering research in ophthalmology has advanced the understanding of retinal diseases and their treatments. Her expertise in ophthalmology is reflected in her leadership of clinical trials and her work as a consultant in specialized fields. Through her research and clinical practice, Dr. Chiosi has established herself as a leader in the evolving field of ophthalmology.
Notable Publication
📝Macular Pigment Changes and Visual Recovery Following Successful Full-Thickness Macular Hole Closure Using the Inverted Flap Technique
Authors: Rinaldi, M., Galantuomo, N., Passaro, M.L., Chiosi, F., Costagliola, C.
Journal: Journal of Clinical Medicine
Year: 2025
📝Regression of the Flow Signal from the Neovascular Network in AMD Neovascular Membranes Treated with Faricimab
Authors: Savastano, M.C., Crincoli, E., Toto, L., Boscia, F., Rizzo, S.
Journal: Diagnostics
Year: 2024
📝Resistive index of central retinal artery, aortic arterial stiffness and OCTA correlated parameters in the early stage of Fabry disease
Authors: Rinaldi, M., Chiosi, F., Passaro, M.L., Limongelli, G., Costagliola, C.
Journal: Scientific Reports
Year: 2024
📝Changes in Macular Pigment Optical Density after Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration: A Pilot Study
Authors: Cennamo, G., Rinaldi, M., Chiosi, F., Costagliola, C.
Journal: Journal of Clinical Medicine
Year: 2024
📝Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review
Authors: Carnevali, A., Bacherini, D., Metrangolo, C., Gallinaro, V., Bonfiglio, V.M.E.
Journal: Frontiers in Medicine
Year: 2024
📝Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy
Authors: Carosielli, M., Carnevali, A., Fallico, M., Vaiano, A., Venturi, F.
Journal: Translational Vision Science and Technology
Year: 2023